Mia's Feed
Medical News & Research

TREM2 Receptor in Alveolar Macrophages Promotes Lung Fibrosis: New Research Insights

TREM2 Receptor in Alveolar Macrophages Promotes Lung Fibrosis: New Research Insights

Share this article

New research highlights the critical role of the TREM2 receptor on alveolar macrophages in promoting lung fibrosis. Blocking TREM2 offers a potential new approach to treat this chronic lung disease.

2 min read

Recent scientific studies have shed light on the role of the alveolar macrophage surface receptor TREM2 in the development of lung fibrosis, a chronic and progressive lung disease. Lung macrophages, essential immune cells present in the lung tissue, include tissue-resident macrophages from birth and monocyte-derived macrophages (Mo-AMs) that enter the lung in response to injury or infection.

In a groundbreaking study published in Nature Communications, researchers from the University of Alabama at Birmingham demonstrated that TREM2, a receptor protein expressed on Mo-AM cells, is a key regulator in the progression of lung fibrosis. The study found that TREM2 is highly expressed on these macrophages, especially in cases of idiopathic pulmonary fibrosis (IPF), and significantly contributes to the prolongation of macrophage survival, which in turn promotes fibrotic activity in the lungs.

The researchers revealed that TREM2 delays apoptosis (programmed cell death) of Mo-AMs, allowing these cells to survive longer in the lung environment. Lipid mediators present in lung surfactant, which normally prevent lung collapse, bind tightly with TREM2, further enhancing macrophage survival and activity. This pro-survival effect of TREM2 has the potential to exacerbate lung fibrosis.

Importantly, the study showed that blocking TREM2 — either through genetic deletion or using specific antibodies — can significantly reduce lung fibrosis in mouse models. Treatments that interfere with TREM2 binding to lipid mediators led to increased apoptosis of Mo-AMs and a decrease in fibrotic tissue development. Notably, these therapeutic interventions remained effective even when administered after fibrosis initiation.

The findings suggest that targeting TREM2 could be a promising strategy for developing new treatments against lung fibrosis, a disease characterized by stiffening of lung tissue that impairs breathing. The ability to attenuate fibrosis by disrupting macrophage survival mechanisms offers hope for future therapeutic options.

For more insight, the full study can be accessed in Nature Communications (2025). Source: https://medicalxpress.com/news/2025-07-alveolar-macrophage-cell-surface-receptor.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Texas Moves to Ease Vaccine Exemptions Amid Measles Outbreak

Texas aims to simplify vaccine exemption procedures amid its largest measles outbreak in decades, raising concerns about public health risks and vaccination coverage.

Increasing Trends in Nonfatal Fentanyl Overdose Emergency Visits Through Q3 2023

Recent CDC research reveals a significant increase in nonfatal fentanyl overdose ED visits through the third quarter of 2023, highlighting ongoing public health concerns and the need for targeted interventions.

Breakthrough AI Model Achieves Expert-Level Accuracy in Non-Invasive Breast Cancer Diagnosis with MRI

A groundbreaking AI model developed by HKUST achieves expert-level accuracy in non-invasive breast cancer diagnosis using multiparametric MRI, supporting personalized treatment strategies.

New Research Links Instant Coffee Consumption to Increased Risk of Macular Degeneration

Recent research suggests that drinking instant coffee may significantly increase the risk of developing age-related macular degeneration, a leading cause of vision loss. Discover the links between genetics, diet, and eye health in this comprehensive overview.